Kumar Arun, Sengupta Sounok, Yadav Ashok Kumar, Singh Raman Preet, Sinha Tripti, Bhattacharjee Pratiti, Basu Biswarup, Marriapan G, Bhattacharyya Sanjib, Kumar Deepak
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, India.
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India.
Future Med Chem. 2025 Jul;17(14):1675-1692. doi: 10.1080/17568919.2025.2539673. Epub 2025 Aug 4.
Cancer is an affliction on societies worldwide, chemotherapy, though effective, has its limitations, indicating the need for new therapeutic agents. Imidazole and indole are two important bioactive heterocycles important for developing newer anticancer molecules.We synthesized a series of substituted imidazole-linked indole derivatives and evaluated them for anticancer activity on MCF-7 cells. Further , cell cycle and apoptosis studies was done for the most active compounds.
Compounds were synthesized by preparing substituted triphenyl imidazoles from benzaldehydes and were further linked to indoles using -chloroalkyl indoles. The synthesized compounds were characterized and tested for anticancer activity using MTT-assay on MCF-7 cells, followed by a cell-cycle and apoptosis assay of most active compound using flow cytometry. The most active compound was subjected to docking studies using PyRx with the EGFR protein 4HJO, followed by a molecular dynamics simulation using Desmond. Finally, DFT calculations were performed using ORCA 6.0 followed by QSAR analysis of the compounds.
Compounds were confirmed by H NMR, C NMR, mass spectroscopy, and showed IC values of 26.52 to 39.05 µM on MCF-7 cells. The most active compound produced apoptosis at its IC in MCF-7 cells and arrested the cell cycle in G2/M phase. also had good interactions with 4HJO which confirmed its stability in both molecular dynamics and DFT studies. QSAR studies predicted the relevant structural features for the biological activity.
癌症是全球社会面临的一大困扰,化疗虽有效但有其局限性,这表明需要新的治疗药物。咪唑和吲哚是两种重要的生物活性杂环,对开发新型抗癌分子很重要。我们合成了一系列取代咪唑连接的吲哚衍生物,并评估了它们对MCF - 7细胞的抗癌活性。此外,还对活性最强的化合物进行了细胞周期和凋亡研究。
通过由苯甲醛制备取代三苯基咪唑来合成化合物,并使用氯烷基吲哚将其进一步与吲哚连接。对合成的化合物进行表征,并使用MTT法在MCF - 7细胞上测试其抗癌活性,随后使用流式细胞术对活性最强的化合物进行细胞周期和凋亡检测。使用PyRx对活性最强的化合物与EGFR蛋白4HJO进行对接研究,随后使用Desmond进行分子动力学模拟。最后,使用ORCA 6.0进行DFT计算,然后对化合物进行QSAR分析。
化合物通过氢核磁共振、碳核磁共振、质谱得到确认,在MCF - 7细胞上的IC值为26.52至39.05 μM。活性最强的化合物在其IC浓度下使MCF - 7细胞发生凋亡,并使细胞周期停滞在G2/M期。该化合物与4HJO也有良好的相互作用,这在分子动力学和DFT研究中都证实了其稳定性。QSAR研究预测了生物活性的相关结构特征。